Navigation Links
Genstruct Names Louis Latino VP of Sales
Date:9/17/2008

CAMBRIDGE, Mass., Sept. 17 /PRNewswire/ -- Genstruct Inc., a systems biology company focused on identifying molecular mechanisms, networks and biomarkers to better develop novel therapeutics and molecular diagnostics, announced today that it has appointed Louis Latino as VP of Sales. As part of Genstruct's executive management team, Mr. Latino will lead the company's global sales efforts, focusing on building the company's sales infrastructure to drive future growth.

In his role as VP of Sales, Mr. Latino will be responsible for managing and expanding partnerships with existing customers while leveraging the Genstruct platform to expand the company's consulting services and partnership business through the development of new partnerships and collaborations within the global biotechnology, pharmaceutical and related industries.

"Earlier this year we launched our Consulting Services division, and we have rapidly grown this business to the point that we need to build a world- class sales team to manage its growth. Lou Latino has both the experience and expertise we need to manage the growth of this business," said Keith O. Elliston, Ph.D., president and CEO of Genstruct. "He is ideally suited to extend the impact of the Genstruct platform throughout the life sciences sector. His wealth of management experience with early-stage companies and his outstanding sales record in the life sciences industry are the key qualities we need to expand our current partnerships and our customer base."

"Genstruct's Causal Network(TM) modeling platform has been vital to the development of safe and effective new drugs for our partners," said Mr. Latino. "As Genstruct's team of scientists and technology experts focus on new approaches to better understand and treat complex diseases, I see this as an opportunity to leverage the company's successes to broaden its impact across the industry."

Mr. Latino has nearly 30 years of senior sales management and direct sales experience. Prior to joining Genstruct, he was VP of North America, Life Sciences Sales and Support for Accelrys, Inc., a developer of a broad range of technologies, including computer-aided-molecular-design and scientific business intelligence software. He honed his life sciences expertise as VP of Worldwide Sales for Geneformatics and as a regional sales manager for Biosym Technologies. In both positions, he exceeded revenue goals and increased profitability for the respective companies, while enhancing the impact of their technologies.

Mr. Latino has also held senior sales positions with Superscape Group, Mitchell Management Systems and BIW Cable Systems. He earned his bachelor's degree in chemistry from Boston College.

About Genstruct

Founded in 2002, Genstruct is a systems biology company focused on elucidating the complexity of biology for the development of safe and effective therapeutics and molecular diagnostics. By developing Causal Network(TM) models for complex biological systems, Genstruct develops a deep molecular understanding of diseases and drug action, and designs mechanistic biomarkers and molecular diagnostics to facilitate drug development and personalized medicine. Genstruct's Consulting Services division engages in short-, mid- and long-term partnerships with top tier pharmaceutical and life sciences companies, to develop new therapeutics and mechanistic biomarkers in the areas of oncology, metabolic disorders, cardiovascular diseases and inflammation. Genstruct was awarded the Bio-IT World 2008 Best Practices Award in the Drug Discovery & Development category for its joint collaboration with Sirtris Pharmaceuticals (a GSK company). Genstruct is a privately held company based in Cambridge, Mass. For more information, please visit http://www.genstruct.com.

Genstruct and the Genstruct logo are registered trademarks and Molecular Epistemics, Knowledge Assembly, and Epistemics Engine are trademarks of Genstruct, Inc. All other trademarks or registered trademarks are properties of their respective owners.

Contact:

Karen Higgins

A & E Communications for Genstruct

(610) 831-5723

khiggins@aandecomm.com


'/>"/>
SOURCE Genstruct Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Genstruct and Sirtris Pharmaceuticals Win Bio-IT Worlds Best Practices Award
2. Genstructs Andrea Matthews Selected for Mass High Techs People to Watch Under 30
3. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
4. Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
5. Axial Biotech Names New VP of Reimbursement and Regulatory Affairs
6. Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US
7. ThermoGenesis Names Tiffany Olson to Board of Directors
8. ArunA Biomedical Names William T. Sharp President and Chief Executive Officer
9. eResearchTechnology Names New Chief Financial Officer
10. HistoRx Names Bill Sullivan Senior Vice President, Diagnostic Operations
11. The TPAA Names Mark Oelschlager President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... 05, 2016 , ... This composition patent, U.S. Patent No. ... The composition claims are not limited to any particular process to make or ... carbon fibers, graphene, and other materials. A continuation application, U.S. Patent App. ...
(Date:12/5/2016)... , Dec. 5, 2016  Renova™ Therapeutics, ... congestive heart failure and other chronic diseases, announced ... the company as Chief Financial Officer (CFO), effective ... with 20 years of experience in financial management ... biotech and software companies. Most recently, Ms. Bovenizer ...
(Date:12/5/2016)... , December 5, 2016 The ... with almost $108 billion of revenue and some $890 ... were spent on global biopharmaceuticals, and this figure is ... Stock-Callers.com has lined up these four equities for assessment: ... Pharmaceuticals Inc. (NASDAQ: ACAD ), Acorda Therapeutics ...
(Date:12/2/2016)... ... ... In anticipation of AxioMed’s exclusive cleanroom manufacturing facility in ... Lubinski will be traveling to Switzerland from December 5-10. Mr. Lubinski will meet ... to discuss the benefits of a viscoelastic disc. AxioMed received CE mark in ...
Breaking Biology Technology:
(Date:11/30/2016)... SAN FRANCISCO and WARSAW, Poland , Nov. 30, 2016 ... sleeping. It is one of the most crucial aspects of recovery so we need ... host of serious health risks, including heart problems, high blood pressure, stroke, diabetes, and ... family and friends sleep and find a Christmas present that could help them to ... ...
(Date:11/29/2016)... Lithuania , Nov. 29, 2016 /PRNewswire/ ... biometric identification and object recognition technologies, today ... (SDK) for fingerprint recognition solutions that run ... a fingerprint template using less than 128KB ... in compact devices that have limited on-board ...
(Date:11/24/2016)... Cercacor today introduced Ember TM Sport ... non-invasively measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion ... in approximately 30 seconds. Smaller than a smartphone, using ... to key data about their bodies to help monitor ... Hemoglobin carries oxygen to muscles. When hemoglobin ...
Breaking Biology News(10 mins):